IMG Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7K Buy
983
+106
+12% +$2.77K 0.01% 237
2026
Q1
$24.6K Sell
877
-2,452
-74% -$65.3K 0.02% 220
2025
Q4
$82.9K Sell
3,329
-859
-21% -$21.7K 0.05% 141
2025
Q3
$107K Hold
4,188
0.07% 119
2025
Q2
$102K Buy
4,188
+1,338
+47% +$31.2K 0.08% 117
2025
Q1
$72.2K Hold
2,850
0.06% 125
2024
Q4
$75.6K Buy
+2,850
New +$77.3K 0.07% 120

Other funds holding PFE

IMG Wealth Management's PFE Position: Q2 2026 in Review

IMG Wealth Management increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $2.77K and bringing the position to 983 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #237.

IMG Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $107K in Q3 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • IMG Wealth Management held 983 shares of Pfizer worth $23.7K as of Q2 2026.
  • IMG Wealth Management bought 106 Pfizer shares in Q2 2026, an estimated $2.77K.
  • Pfizer made up 0.01% of IMG Wealth Management's portfolio in Q2 2026, its #237 holding.
  • IMG Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • IMG Wealth Management's Pfizer position peaked at $107K in Q3 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.